Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...

A flagship new SA Ambulance Service headquarters at Mile End South is a gamechanger for the organisation, says chief executive officer Rob Elliott.

For decades, hearing loss meant one thing: expensive, complicated hearing aids that required specialist appointments, ...

Can pool noodles really breathe new life into your old, saggy couch cushions? We put this hack to the test and were impressed ...

Maximize space and style in a small kitchen with smart essentials while avoiding bulky, unnecessary items that only add ...

Positive alternative endpoint findings did not correlate highly with OS or QoL endpoints. The researchers suggest that late-phase clinical trial design should focus on OS and QoL improvements to ...

From getting access to the latest treatments to playing an active role in advancing cancer care, there are many benefits to participating in a clinical trial for cancer.

With these Wirecutter-approved picks under $100, you don’t have to spend a lot to get a good deal this Amazon Prime Day.

Amgen Inc. (NASDAQ:AMGN) is one of the 11 most profitable NASDAQ stocks to buy now. On June 2, Amgen announced new interim results from the global Phase 3 DeLLphi-304 trial for its drug IMDELLTRA ...

By Kelly Cloonan Cue Biopharma has received positive feedback from the Food and Drug Administration for its first in-human trial design for CUE-401, a protein that aims to treat autoimmune disease.

Shorter-form messaging seems to be preferable for recruiting participants to enroll in clinical trials, according to a research letter published online June 25 in the Journal of the American Medical ...